… If AAA growth rates can be attenuated or halted in this … (RAS) in AAA formation and growth.
A case–control study on a … received an angiotensin-converting enzyme inhibitor (ACE-I) but …

… The aim of this review was to compare outcomes and adverse events between ACE … blood
pressure compared with angiotensin-converting enzyme inhibitors and direct renin inhibitors. …

… Angiotensin-converting enzyme inhibitors (… angiotensin converting enzyme 2 (ACE2) which
produces Ang (1–7), the main counter-regulatory mediator of angiotensin II. This enzyme is …

… or ARBs, or to their mechanisms of action. Angiotensin-converting enzyme inhibitors target
angiotensin-converting enzyme 1 (ACE) to inhibit conversion of angiotensin I to angiotensin II…

… evidence to change the use of angiotensin-converting enzyme inhibitors (ACEIs) or
angiotensin … In this article, we review the evidence on the relationship between the renin-angiotensin-…

… According to the latest analysis of the National Health and Nutrition Examination Survey
ACEIs/ARBs are the most prevalent antihypertensive medication among all drug classes. …

… (angiotensin-converting enzyme [ACE] inhibitors or angiotensin II receptor lockers [ARB])
reduced albuminuria and the risk of progressive decrease in glomerular filtration rate (… -analysis …

… Multiple trials over the past several years have examined the effects of both angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in the …

… Angiotensin-converting enzyme inhibitor monotherapy as well as combinations of ACE
inhibitors and … For the analysis of central nervous system malformations (C), we assume 20% of …

… The search strategy was: “(angiotensin converting enzyme OR ACE inhibitor OR ACE OR …
The meta-analysis of AAA growth rate outcomes was reported as summary estimates of …